Mary Lee
Family · Hopkinsville, KYNPI 1790396828
Payments from drug & device makers
Across 299 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$578
- Amgen$487
- Actelion Pharmaceuticals US, Inc.$441
- Boehringer Ingelheim$351
- Regeneron Healthcare Solutions, Inc.$349
- plus $2K from 37 others
What the payments were for
- Food & beverage$5,47299%
- Education$791%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,551 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 113 | $111,453 |
| OzempicSemaglutide | 87 | $104,201 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $58,923 |
| MounjaroTirzepatide | 52 | $52,767 |
| JanuviaSitagliptin Phosphate | 38 | $39,337 |
| LinzessLinaclotide | 47 | $33,309 |
| EliquisApixaban | 23 | $30,939 |
| JardianceEmpagliflozin | 25 | $26,399 |
| TrulicityDulaglutide | 32 | $22,890 |
| Repatha SureclickEvolocumab | 22 | $22,618 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $19,673 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 36 | $18,250 |
| RybelsusSemaglutide | 11 | $14,066 |
| XareltoRivaroxaban | 24 | $12,941 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $12,017 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,034 | $136,733149 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $115 | $121,547109 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $578 | $98,852160 claims |
| Lilly USA, LLCMounjaro, Trulicity | $170 | $75,65784 claims |
| MerckJanuvia | $62 | $39,33738 claims |
| AbbVieLinzess | $83 | $33,30947 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $351 | $31,98537 claims |
| PfizerEliquis | $34 | $30,93923 claims |
| Johnson & JohnsonXarelto | $154 | $12,94124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Hopkinsville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.